5-Amino-1MQ vs L-692,429

Head-to-head comparison of 5-Amino-1MQ (5-Amino-1-methylquinolinium) and L-692,429 (L-692,429) — benefits, dosing, side effects, research data, and where to buy.

Research Score

Property5-Amino-1MQL-692,429
CategoryWeight ManagementGrowth Hormone
Full Name5-Amino-1-methylquinoliniumL-692,429
Molecular Weight178.23 g/molN/A
Half-Life~6 hoursunknown / study-dependent
Amino AcidsSmall moleculeN/A
Typical Dose0.03-0.1 mg/kg
RouteOral
Purity>98%≥98%
Studies Count2830
Research StatusActive ResearchPre-clinical

5-Amino-1MQ Benefits

  • Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production

L-692,429 Benefits

  • potent GHSR agonism
  • oral bioactivity in models
  • validates ghrelin pathway
  • useful research probe

5-Amino-1MQ Dosing

Research doses: 50-150 mg orally daily. Often cycled 8-12 weeks on, 4 weeks off. Best taken in the morning.

L-692,429 Dosing

0.03-0.1 mg/kg in early studies|single oral or short-course research dosing|serial GH sampling recommended

5-Amino-1MQ Side Effects

  • Generally well-tolerated in preclinical models. Potential mild GI discomfort and headache. Long-term human safety data is limited.

L-692,429 Side Effects

  • increased appetite
  • glucose intolerance
  • transient prolactin changes

Research Overview

5-Amino-1MQ

Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.

L-692,429

L-692,429 was important in early GH secretagogue research because it showed that nonpeptide molecules could trigger robust GH release. It remains a classic tool compound for studying receptor-mediated GH pulsatility and appetite signaling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

5-Amino-1MQ stacks with:

AOD-9604MOTS-cCJC-1295

L-692,429 stacks with:

Receptor assaysEndocrine studies
weight-lossNNMT-inhibitorfat-lossmetabolismNAD+tool-compoundgh-secretagogueghrelin-pathway